These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22619890)

  • 1. N-terminal-pro-brain natriuretic peptide for the differential diagnosis of hypovolemia vs. euvolemia in hyponatremic patients.
    Bunnag S; Pattanasombatsakul K
    J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S69-74. PubMed ID: 22619890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of NT-ProBNP as a marker of the volume status of neurosurgical patients developing hyponatremia and natriuresis: A pilot study.
    Tobin G; Chacko AG; Simon R
    Neurol India; 2018; 66(5):1383-1388. PubMed ID: 30233009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
    Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
    Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro-B-type natriuretic peptide in patients with isolated traumatic brain injury: a prospective cohort study.
    Wu X; Sha H; Sun Y; Gao L; Liu H; Yuan Q; Zhang T; Zhu J; Zhou L; Hu J
    J Trauma; 2011 Oct; 71(4):820-5; discussion 825. PubMed ID: 21808206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock.
    Vergès B; Zeller M; Desgrès J; Dentan G; Laurent Y; Janin-Manificat L; L'Huillier I; Rioufol G; Beer JC; Makki H; Rochette L; Gambert P; Cottin Y
    Eur Heart J; 2005 Sep; 26(17):1734-41. PubMed ID: 15831555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic value of N terminal pro B type natriuretic peptide in critically ill patients].
    Li ZH; Xiao J; Li JZ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Mar; 23(3):179-82. PubMed ID: 21366951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.
    Jarai R; Fellner B; Haoula D; Jordanova N; Heinz G; Karth GD; Huber K; Geppert A
    Crit Care Med; 2009 Jun; 37(6):1837-44. PubMed ID: 19384228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population.
    Kotanidou A; Karsaliakos P; Tzanela M; Mavrou I; Kopterides P; Papadomichelakis E; Theodorakopoulou M; Botoula E; Tsangaris I; Lignos M; Ikonomidis I; Ilias I; Armaganidis A; Orfanos SE; Dimopoulou I
    Shock; 2009 Apr; 31(4):342-7. PubMed ID: 18791494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
    Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
    Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
    N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in B-type natriuretic peptides after surgical ventricular restoration.
    Sartipy U; Albåge A; Larsson PT; Insulander P; Lindblom D
    Eur J Cardiothorac Surg; 2007 May; 31(5):922-8. PubMed ID: 17321144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study).
    O'Donoghue M; Kenney P; Oestreicher E; Anwaruddin S; Baggish AL; Krauser DG; Chen A; Tung R; Cameron R; Januzzi JL
    Am J Cardiol; 2007 Nov; 100(9):1336-40. PubMed ID: 17950786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass.
    Feringa HH; Bax JJ; Elhendy A; de Jonge R; Lindemans J; Schouten O; van den Meiracker AH; Boersma E; Schinkel AF; Kertai MD; van Sambeek MR; Poldermans D
    Am J Cardiol; 2006 Jul; 98(1):111-5. PubMed ID: 16784932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients.
    Meyer B; Huelsmann M; Wexberg P; Delle Karth G; Berger R; Moertl D; Szekeres T; Pacher R; Heinz G
    Crit Care Med; 2007 Oct; 35(10):2268-73. PubMed ID: 17717488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery.
    Chong CP; Ryan JE; van Gaal WJ; Lam QT; Sinnappu RN; Burrell LM; Savige J; Lim WK
    Am J Cardiol; 2010 Sep; 106(6):865-72. PubMed ID: 20816130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of serial N-terminal pro-B-type natriuretic peptide measurements for determining prognosis in patients with pulmonary arterial hypertension.
    Mauritz GJ; Rizopoulos D; Groepenhoff H; Tiede H; Felix J; Eilers P; Bosboom J; Postmus PE; Westerhof N; Vonk-Noordegraaf A
    Am J Cardiol; 2011 Dec; 108(11):1645-50. PubMed ID: 21890089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain natriuretic peptide is a good predictor for outcome in cardiac surgery.
    Elíasdóttir SB; Klemenzson G; Torfason B; Valsson F
    Acta Anaesthesiol Scand; 2008 Feb; 52(2):182-7. PubMed ID: 17949462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro-brain natriuretic peptide and outcomes in patients undergoing surgical ventricular restoration.
    Ballotta A; Ranucci M; Kunkl A; El Baghdady H; Bossone E; Castelvecchio S; Frigiola A; Menicanti L; Di Donato M; Mehta RH
    Am J Cardiol; 2010 Mar; 105(5):640-4. PubMed ID: 20185010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.
    Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H
    Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.